Why is everyone talking about Xero shares?

Xero shares have continued falling.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • Xero shares are at an 18-month low of $122.22, down 28.34% year over year, following concerns over an unexpected FY25 result and a large acquisition.
  • Despite a 20% increase in operating revenue and a 21% EBITDA growth reported in its FY26 interim results, investors remain cautious due to high operating expenses.
  • Analysts, including Macquarie, regard the sell-off as unjustified, maintaining an outperform rating with a target price suggesting up to 88.4% upside potential over the next 12 months.

Xero Ltd (ASX: XRO) shares plunged nearly 15% last week and have remained relatively flat so far this week. At the time of writing, ahead of the ASX open on Tuesday, the shares are at an 18-month low of $122.22 a piece. The shares are now 28.34% lower than this time last year.

A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate

Image source: Getty Images

What happened?

It's been a rollercoaster year for the cloud-based accounting software company's stock. Over the past 6 months, Xero shares have dropped 32.65% after the company announced a lower-than-expected FY25 result in May, followed by news of its US$2.5 billion acquisition of US-based Melio in July. 

The move spooked investors who sold off shares in a panic about the deal's size and projected cash flow. The deal was completed in mid-October, but investor confidence still doesn't appear to have recovered. 

On Thursday last week, Xero released its FY26 interim results. For the six months ended 30 September, Xero reported an impressive 20% increase in operating revenue to NZ$1,194 million. This was driven by ANZ revenue growth of 17% and a 24% jump in International revenue. Xero's EBITDA increased 21% to NZ$377.9 million. The company's net operating result was a little behind expectations, but its EBITDA was ahead.

But investors are reacting cautiously. This could be because the company also reported that total operating expenses as a percentage of revenue are now expected to be around 70.5% in FY26. Although, it's an improvement on the 71.5% that Xero previously expected.

What do analysts think of Xero shares?

Analysts think this year's investor sell-off is unfounded. 

Just yesterday, analysts at Macquarie said they think the market has it wrong on Xero shares. In a note to investors, the broker said there is nothing in Xero's latest results that explains the sell-off. It added that its newly acquired Melio business is performing on track, and with the deal closing earlier than expected, the company could start cross-selling products as soon as December.

Macquarie has an outperform rating and $230.30 12-month target price on Xero shares. At the time of writing, this implies a potential 88.4% upside for investors.

The broker isn't the only one, either. TradingView data shows that out of 15 analysts, 12 have a buy or strong buy rating on Xero shares. The maximum target price is $230.60, while the average is $184.66. These represent a potential upside of anywhere from 51.09% to 88.68% over the next 12 months.

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group and Xero. The Motley Fool Australia has positions in and has recommended Macquarie Group and Xero. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Technology Shares

A woman scratches her head, thinking is this a no-brainer?
Technology Shares

Down 65%: Are Pro Medicus shares in the buy zone yet?

Pro Medicus has had one of its toughest periods yet...

Read more »

Red arrow going down, symbolising a falling share price.
Technology Shares

Why is this battered ASX tech stock losing big today?

Analysts remain bullish and see 110% upside for the growth share.

Read more »

A dollar sign embedded in ice, indicating a share price freeze or trading halt
Technology Shares

This ASX tech stock is frozen today. Here's what's going on

ASX tech stock enters halt as a capital raising looms.

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Technology Shares

Which ASX tech stock is surging 11% on strong trading update?

Let's see what is getting investors excited on Thursday.

Read more »

Two IT professionals walk along a wall of mainframes in a data centre discussing various things
Technology Shares

Which data centre operator just upgraded its earnings outlook?

The sector is experiencing strong demand.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Technology Shares

Guess which ASX defence stock is jumping 20% on US Navy contract

Management believes the deal is a significant milestone.

Read more »

A young woman wearing glasses and a red top looks at her laptop smiling
Technology Shares

Catapult Sports delivers strong FY26 growth and profitability

Catapult Sports delivered record ACV growth and a sharp lift in profitability in its latest FY26 trading update.

Read more »

A man sits nervously at his computer with his mouth resting against his hands clasped in front of him as he stares at the screen of his computer on a home desk.
Technology Shares

Here are expert views on whether the Xero share price is a buy amid AI concerns

Is Xero exposed to AI? Here’s an expert’s view on the ASX tech share.

Read more »